2026 Medical Utilization Forecasts Support BTIG's Bullish View on LifeStance (LFST)
On December 12, BTIG analyst David Larsen reiterated his bullish stance on LifeStance Health Group (NASDAQ:LFST). The analyst rated the stock as Buy and raised the price target from $9 to $10 a share.







